PMC:7200337 / 26796-27064
Annnotations
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32505227-26251193-46575293 | 262-266 | 26251193 | denotes | 2015 |
T84673 | 262-266 | 26251193 | denotes | 2015 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T259 | 162-170 | Body_part | denotes | NK cells | http://purl.org/sig/ont/fma/fma63147 |
T260 | 165-170 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T280 | 55-58 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T281 | 131-132 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T282 | 162-170 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cells |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T116 | 24-26 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T118 | 41-43 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T120 | 156-161 | Chemical | denotes | donor | http://purl.obolibrary.org/obo/CHEBI_17891 |
T121 | 216-227 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T122 | 229-231 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T111 | 122-143 | http://purl.obolibrary.org/obo/GO_0071613 | denotes | granzyme B production |
T112 | 229-234 | http://purl.obolibrary.org/obo/GO_0004915 | denotes | IL-6R |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
858 | 24-28 | Gene | denotes | IL-6 | Gene:3569 |
859 | 122-132 | Gene | denotes | granzyme B | Gene:3002 |
860 | 229-234 | Gene | denotes | IL-6R | Gene:3570 |
879 | 216-227 | Chemical | denotes | tocilizumab | MESH:C502936 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T150 | 0-268 | Sentence | denotes | In vitro stimulation by IL-6 and soluble IL-6 receptor has previously revealed impaired cytolytic functions (perforin and granzyme B production) by healthy donor NK cells, which can be restored following addition of tocilizumab (IL-6R blockade) (Cifaldi et al., 2015). |